Showing results (2541-2550 of 2,852) with videos related to

Sort By:
Pageof 286
Bone|September 17, 2008
International Society for Clinical Densitometry 2007 Adult and Pediatric Official PositionsE Michael Lewiecki, Catherine M Gordon, Sanford Baim, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 25, 2009
CNTF 1357 G -> A polymorphism and the muscle strength response to resistance trainingSean Walsh, Bethany K Kelsey, Theodore J Angelopoulos, et al.
Nature Communications|April 15, 2020
An in vivo platform to select and evolve aggregation-resistant proteinsJessica S Ebo, Janet C Saunders, Paul W A Devine, et al.
Cytokine|June 3, 2008
Interleukin-15 and interleukin-15R alpha SNPs and associations with muscle, bone, and predictors of the metabolic syndromeEmidio E Pistilli, Joseph M Devaney, Heather Gordish-Dressman, et al.
Medicine and Science in Sports and Exercise|June 16, 2006
ACE ID genotype and the muscle strength and size response to unilateral resistance trainingLinda S Pescatello, Matthew A Kostek, Heather Gordish-Dressman, et al.
Research in Nursing & Health|December 15, 2020
Implementing remote triage in large health systems: A qualitative evidence synthesisAllison A Lewinski, Sharron Rushton, Elizabeth Van Voorhees, et al.
BMC Medical Genetics|December 25, 2008
INSIG2 gene polymorphism is associated with increased subcutaneous fat in women and poor response to resistance training in menFunda E Orkunoglu-Suer, Heather Gordish-Dressman, Priscilla M Clarkson, et al.
Journal of General Internal Medicine|January 4, 2020
Effectiveness of Acute Care Remote Triage Systems: a Systematic ReviewJoel C Boggan, John Paul Shoup, John D Whited, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 3, 2020
Suppression of Serum Interferon-γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus ErythematosusMatteo Cesaroni, Loqmane Seridi, Matthew J Loza, et al.
ESMO Open|May 13, 2025
A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancerM A Gouda, M H Voss, H Tawbi, et al.
Pageof 286